Next-Gen Data Access for Pharma: How Integrated Data Ecosystems Are Powering Global Pharma Decision-Making
Introduction: In today’s dynamic pharmaceutical landscape, the need for seamless data access and faster decision-making has made AI-powered, cloud-based solutions a cornerstone of innovation. As a pharma company that works across multiple therapy areas simultaneously, traditional data silos have proven inefficient for providing insights into country-specific disease burden, epidemiology research, and, essentially, market forecasts. To address these challenges, Thelansis developed an AI-enabled cloud platform that transforms how organizations access, analyze, and apply epidemiology and market insights. This case study explores how Thelansis partnered with a global biopharma client to streamline their research processes. Objective: A client with a diverse product portfolio sought a centralized, scalable, and Competitive Intelligence system to access reliable epidemiology and disease landscape insights. Our team collaborated with theirs to understand their requirements, based on the...